Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-25-000072
Filing Date
2025-11-05
Accepted
2025-11-04 18:59:36
Documents
82
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20250930.htm   iXBRL 10-Q 2361893
2 LETTER AGREEMENT BY AND BETWEEN AMGEN INC. AND BEONE MEDICINES exhibit10194-letteragreeme.htm EX-10.19 4 22101
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_20250930x10xq.htm EX-31 19602
4 SECTION 1350 CERTIFICATIONS amgn-ex32_20250930x10xq.htm EX-32 9435
10 GRAPHIC beonelogowhitea.jpg GRAPHIC 97345
  Complete submission text file 0000318154-25-000072.txt   10725588

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20250930.xsd EX-101.SCH 53793
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20250930_cal.xml EX-101.CAL 67462
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20250930_def.xml EX-101.DEF 330680
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20250930_lab.xml EX-101.LAB 660126
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20250930_pre.xml EX-101.PRE 499574
84 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20250930_htm.xml XML 2039587
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 251451175
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)